Combination Therapy With 3BNC117 and 10-1074 in HIV-Infected Individuals

NCT03571204 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

27

Enrollment

NIH

Sponsor class

Stopped Coronavirus 2019 (COVID-19) pandemic

Conditions

HIV

Interventions

BIOLOGICAL: 3BNC117 and 10-1074
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)